Although traditionally regarded as an anti-inflammatory molecule, TGF-β actively shapes the inflammatory milieu within tumors by promoting tissue remodeling and inhibiting antigen-specific CD8+ T cell activity in the local tumor microenvironment [7]. This evidence concerns the gene TGFB1 and neoplasm.